Drug-resistant HIV-1 protease regains functional dynamics through cleavage site coevolution

Evolutionary Applications

Volumn 8, Issue 2, 2015, Pages 185-198

  Özer, Nevra ^a,c   Özen, Ayşegül ^b   Schiffer, Celia A ^b   Haliloğlu, Türkan ^a  

^a BOGAZICI UNIVERSITY   (Turkey)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Coevolution; Elastic network model; Fluctuations; HIV 1 protease

Indexed keywords

EID: 84921633526     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12241     Document Type: Article

References (63)

1. Atilgan, A. R., S. R. Durell, R. L. Jernigan, M. C. Demirel, O. Keskin, and I. Bahar 2001. Anisotropy of fluctuation dynamics of proteins with an elastic network model. Biophysical Journal 80:505-515.
2. Bahar, I., A. R. Atilgan, and B. Erman 1997. Direct evaluation of thermal fluctuations in proteins using a single parameter harmonic potential. Folding and Design 2:173-181.
3. Bahar, I., A. R. Atilgan, M. C. Demirel, and B. Erman 1998. Vibrational dynamics of folded proteins: significance of slow and fast motions in relation to function and stability. Physical Review Letters 80:2733-2736.
4. Bahar, I., T. R. Lezon, L. Yang, and E. Eyal 2010. Global dynamics of proteins: bridging between structure and function. Annual Review of Biophysics 39:23-42.
5. Bakan, A., and I. Bahar 2009. The intrinsic dynamics of enzymes plays a dominant role in determining the structural changes induced upon inhibitor binding. Proceedings of the National Academy of Sciences of the United States of America 106:14349-14354.
6. Bally, F., R. Martinez, S. Peters, P. Sudre, and A. Telenti 2000. Polymorphism of HIV-1 type 1 Gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors. AIDS Research and Human Retroviruses 16:1209-1213.
7. Berkhout, B., and R. W. Sanders 2005. The evolvability of drug resistance: the HIV-1 case. Journal of Biomolecular Structure and Dynamics 22:619-621.
8. Bernstein, E. E., T. F. Koetzle, G. J. B. Williams, J. E. F. Meyer, M. D. Brice, J. R. Rodgers, O. Kennard et al. 1977. The Protein Data Bank: a computer-based archival file for macromolecular structures. Journal of Molecular Biology 117:535-542.
9. Chennubhotla, C., A. J. Rader, L. Yang, and I. Bahar 2005. Elastic network models for understanding biomolecular machinery: from enzymes to supramolecular assemblies. Physical Biology 2:S173-S180.
10. Creavin, T. 2004. Evolvability: implications for drug design. Drug Discovery Today: Targets 3:178.
11. Cui, Q., and I. Bahar 2005. Normal Mode Analysis: Theory and Applications to Biological and Chemical Systems. CRC Press, Boca Raton, FL.
12. Doyon, L., G. Croteau, D. Thibeault, F. Poulin, L. Pilote, and D. Lamarre 1996. Second locus involved in human immunodeficiency virus Type 1 resistance to protease inhibitors. Journal of Virology 78:3763-3769.
13. Earl, D. J., and M. W. Deem 2004. Evolvability is a selectable trait. Proceedings of the National Academy of Sciences of the United States of America 101:11531-11536.
14. Feher, A., I. T. Weber, P. Bagossi, P. Boross, B. Mahalingam, J. M. Louis, T. D. Copeland et al. 2002. Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites. European Journal of Biochemistry 269:4114-4120.
15. Feig, M., J. Karanicolas, and C. L. Brooks 2004. MMTSB Tool Set: enhanced sampling and multiscale modeling methods for applications in structural biology. Journal of Molecular Graphics and Modelling 22:377-395.
16. Ferreiro, D. U., J. A. Hegler, E. A. Komives, and P. G. Wolynes 2011. On the role of frustration in the energy landscapes of allosteric proteins. Proceedings of the National Academy of Sciences of the United States of America 108:3499-3503.
17. Friedland, G. D., N. A. Lakomek, C. Griesinger, J. Meiler, and T. Kortemme 2009. A correspondence between solution-state dynamics of an individual protein and the sequence and conformational diversity of its family. PLoS Computational Biology 5:1-16.
18. Gerek, Z. N., S. Kumar, and S. B. Ozkan 2013. Structural dynamics flexibility informs function and evolution at a proteome scale. Evolutionary Applications 6:423-433.
19. Gerstein, M., and N. Echols 2004. Exploring the range of protein flexibility, from a structural proteomics perspective. Current Opinion in Chemical Biology 8:14-19.
20. Gniewek, P., A. Kolinski, R. L. Jernigan, and A. Kloczkowski 2012. Elastic network normal modes provide a basis for protein structure refinement. The Journal of Chemical Physics 136:195101-195110.
21. Haliloglu, T., I. Bahar, and B. Erman 1997. Gaussian dynamics of folded proteins. Physical Review Letters 79:3090-3093.
22. Hamacher, K. 2010. Temperature dependence of fluctuations in HIV-1 protease. European Biophysics Journal: EBJ 39:1051-1056.
23. Hamacher, K., and J. A. McCammon 2006. Computing the amino acid specificity of fluctuations in biomolecular systems. Journal of Chemical Theory and Computation 2:873-878.
24. Hornak, V., and C. Simmerling 2007. Targeting structural flexibility in HIV-1 protease inhibitor binding. Drug Discovery Today 12:132-138.
25. Juan, D., F. Pazos, and A. Valencia 2008. Coevolution and co-adaptation in protein networks. FEBS Letters 582:1225-1230.
26. King, N., M. Prabu-Jeyabalan, E. A. Nalivaika, and C. A. Schiffer 2004. Combating susceptibility to drug resistance: lessons from HIV-1 protease. Chemistry and Biology 11:1333-1338.
27. Kolli, M., S. Lastere, and C. A. Schiffer 2006. Coevolution of nelfinavir-resistant HIV-1 protease and the p1-p6 substrate. Virology 347:405-409.
28. Kolli, M., E. Stawiski, C. Chappey, and C. A. Schiffer 2009. Human Immunodeficiency Virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance. Journal of Virology 83:11027-11042.
29. Kurt, N., W. R. Scott, C. A. Schiffer, and T. Haliloglu 2003. Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations. Proteins 51:409-422.
30. Lebon, F., and M. Ledecq 2000. Approaches to the design of effective HIV-1 protease inhibitors. Current Medicinal Chemistry 7:455-477.
31. Liu, Y., and I. Bahar 2012. Sequence evolution correlates with structural dynamics. Molecular Biology and Evolution 29:2253-2263.
32. Lovell, S. C., and D. L. Robertson 2010. An integrated view of molecular coevolution in protein-protein interactions. Molecular Biology and Evolution 27:2567-2575.
33. Lyman, E., and D. M. Zuckerman 2006. Ensemble-based convergence analysis of biomolecular trajectories. Biophysical Journal 91:164-172.
34. Ma, J. 2005. Usefulness and limitations of normal mode analysis in modeling dynamics of biomolecular complexes. Structure 13:373-380.
35. Maguid, S., S. Fernandez-Alberti, G. Parisi, and J. Echave 2008. Evolutionary conservation of protein vibrational dynamics. Gene 422:7-13.
36. Marianayagam, N. J., and S. E. Jackson 2005. Native-state dynamics of the ubiquitin family: implications for function and evolution. Journal of the Royal Society Interface 2:47-54.
37. Micheletti, C., P. Carloni, and A. Maritan 2004. Accurate and efficient description of protein vibrational dynamics: comparing molecular dynamics and Gaussian models. Proteins 55:635-645.
38. Mittal, S., Y. Cai, M. N. Nalam, D. N. A. Bolon, and C. A. Schiffer 2012. Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease. Journal of the American Chemical Society 134:4163-4168.
39. Nalam, M. N., and C. A. Schiffer 2008. New approaches to HIV protease inhibitor drug design II: testing the substrate envelope hypothesis to avoid drug resistance and discover robust inhibitors. Current Opinion in HIV and AIDS 6:642-646.
40. Nicholson, L. K., T. Yamazaki, D. A. Torchia, S. Grzesiek, A. Bax, S. J. Stahl, J. D. Kaufman et al. 1995. Flexibility and function in HIV-1 protease. Nature Structural and Molecular Biology 2:274-280.
41. Nicolay, S., and Y. H. Sanejouand 2006. Functional modes of proteins are among the most robust. Physical Review Letters 96:078104.
42. Ozen, A., T. Haliloglu, and C. A. Schiffer 2011. Dynamics of preferential substrate recognition in HIV-1 protease: redefining the substrate envelope. Journal of Molecular Biology 410:726-744.
43. Ozen, A., T. Haliloglu, and C. A. Schiffer 2012. HIV-1 protease and substrate coevolution validates the substrate envelope as the substrate recognition pattern. Journal of Chemical Theory and Computation 8:703-714.
44. Ozer, N., C. A. Schiffer, and T. Haliloglu 2010. Rationale for more diverse inhibitors in competition with substrates in HIV-1 protease. Biophysical Journal 99:1650-1659.
45. Perryman, A. L., J. Lin, and J. A. McCammon 2004. HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs. Protein Science 13:1108-1123.
46. Prabu-Jeyabalan, M., E. Nalivaika, and C. A. Schiffer 2002. Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes. Structure 10:369-381.
47. Prabu-Jeyabalan, M., E. A. Nalivaika, N. M. King, and C. A. Schiffer 2004. Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease. Journal of Virology 78:12446-12454.
48. Ramanathan, A., and P. K. Agarwal 2011. Evolutionarily conserved linkage between enzyme fold, flexibility, and catalysis. PLoS Biology 9:1-17.
49. del Sol, A., H. Fujihashi, D. Amoros, and R. Nussinov 2006. Residues crucial for maintaining short paths in network communication mediate signaling in proteins. Molecular Systems Biology 2:1-12.
50. Teague, S. J. 2003. Implications of protein flexibility for drug discovery. Nature 2:527-541.
51. Thompson, J. N. 1994. The Coevolutionary Process. University of Chicago Press, Chicago, IL.
52. Tirion, M. M. 1996. Large amplitude elastic motions in proteins from a single-parameter, atomic analysis. Physical Review Letters 77:1905-1908.
53. Tomatis, P. E., S. M. Fabiane, F. Simona, P. Carloni, B. J. Sutton, and A. J. Vila 2008. Adaptive protein evolution grants organismal fitness by improving catalysis and flexibility. Proceedings of the National Academy of Sciences of the United States of America 105:20605-20610.
54. Tournier, A. L., and J. C. Smith 2003. Principal components of the protein dynamical transition. Physical Review Letters 91:208106.
55. Tözser, J., I. Blaha, T. D. Copeland, E. M. Wondrak, and S. Oroszlan 1991. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins. FEBS Letters 281:77-80.
56. Tozzini, V., and J. A. McCammon 2005. A coarse grained model for the dynamics of flap opening in HIV-1 protease. Chemical Physics Letters 413:123-128.
57. Wlodawer, A., and J. W. Erickson 1993. Structure-based inhibitors of HIV-1 protease. Annual Review of Biochemistry 62:543-585.
58. Xia, Y., and M. Levitt 2004. Simulating protein evolution in sequence and structure space. Current Opinion in Structural Biology 14:202-207.
59. Yang, L., and I. Bahar 2005. Coupling between catalytic site and collective dynamics: a requirement for mechanochemical activity of enzymes. Structure 13:893-904.
60. Yang, L., G. Song, A. Carriquiry, and R. L. Jernigan 2008. Close correspondence between the motions from principal component analysis of multiple HIV-1 protease structures and elastic network modes. Structure 16:321-330.
61. Yang, H., J. Nkeze, and R. Y. Zhao 2012. Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy. Cell & Bioscience 2:32.
62. Zheng, W., and B. Brooks 2005. Identification of dynamical correlations within the myosin motor domain by the normal mode analysis of an elastic network model. Journal of Molecular Biology 346:745-759.
63. Zoete, V., O. Michielin, and M. Karplus 2002. Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility. Journal of Molecular Biology 315:21-52.